Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area dna damage dna hdac'

Search results for: 'research area dna damage dna hdac'

Items 21-30 of 67

Page
per page
  1. ITF2357 (Givinostat)
    A4093 ITF2357 (Givinostat)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      ≥23.8 mg/mL
  2. CUDC-907
    A4097 CUDC-907
    Target: Histone Deacetylases (HDACs)|PI3K
    Summary: Potent PI3K/HDAC inhibitor
      ≥25.45 mg/mL
  3. Panobinostat (LBH589)
    A8178 Panobinostat (LBH589)
     10 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥17.47 mg/mL
  4. Trichostatin A (TSA)
    A8183 Trichostatin A (TSA)
     13 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; ≥15.12 mg/mL
  5. M344
    A4105 M344
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor,potent and cell-permeable
  6. Valproic acid sodium salt (Sodium valproate)
    A4099 Valproic acid sodium salt (Sodium valproate)
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      ≥8.35 mg/mL
  7. JNJ-26481585
    A4090 JNJ-26481585
     3 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Potent HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥19.2 mg/mL
  8. Vorinostat (SAHA, MK0683)
    A4084 Vorinostat (SAHA, MK0683)
     9 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.41 mg/mL
  9. Mocetinostat (MGCD0103, MG0103)
    A4089 Mocetinostat (MGCD0103, MG0103)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor,isotype-selective and potent
      insoluble in EtOH; insoluble in H2O; ≥19.8 mg/mL
  10. Temozolomide
    B1399 Temozolomide
    Summary: DNA methylating, chemotherapeutic agent
      insoluble in EtOH; insoluble in H2O; ≥29.61 mg/mL

Items 21-30 of 67

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 1 item
  2. Apoptosis 3item
  3. Chromatin/Epigenetics 29item
  4. Metabolism 1 item
  5. DNA Damage/DNA Repair 45item
  6. PI3K/Akt/mTOR Signaling 8item
  7. Microbiology & Virology 2item
  8. Cell Cycle/Checkpoint 3item
  9. Ubiquitination/ Proteasome 2item
  10. JAK/STAT Signaling 4item
  11. GPCR/G protein 1 item
  12. Others 3item
  13. Immunology/Inflammation 1 item
Reversibility
  1. Reversible 4item
Target
  1. Histone Deacetylases (HDACs) 23item
  2. Akt 1 item
  3. PI3K 5item
  4. mTOR 3item
  5. AP-1 1 item
  6. Chk 2item
  7. Thymidylate Synthase 1 item
  8. STAT 3item
  9. JAK 1 item
  10. DNA-PK 5item
  11. Topoisomerases 5item
  12. DNA Methyltransferases 3item
  13. Ubiquitin-specific proteases 1 item
  14. Fatty-acid-binding proteins (FABPs) 1 item
  15. ATM/ATR 2item
  16. BLM 1 item
  17. HSV 1 item
  18. Synthases/Synthetases 2item
  19. MAGL 1 item
  20. RNA Polymerases 1 item
  21. CMV 1 item
  22. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  23. Cytidine deaminases 1 item
  24. HDAC 1 item
  25. ATM 1 item
  26. Sirtuin 1 item
Reported Experiments
  1. Animal Experiments 62item
  2. Cell Experiments 40item
Related Disease
  1. Acute Myelogenous Leukemia 3item
  2. Acute Myeloid Leukemia 1 item
  3. Acute Renal Failure 1 item
  4. Bladder Cancer 2item
  5. Bladder Carcinoma 1 item
  6. Bladder Diseases 1 item
  7. Breast Cancer 18item
  8. Cancer 54item
  9. Cervical Cancer 2item
  10. Chronic Lymphocytic Leukemia 1 item
  11. Colon Cancer 12item
  12. Colorectal Cancer 6item
  13. Dyskinesia 1 item
  14. Friedreich's Ataxia 1 item
  15. Glioblastoma 3item
  16. Glioma 2item
  17. Hepatic Cancer 1 item
  18. Hepatocellular Carcinoma 3item
  19. HIV Infections 2item
  20. Inflammatory Diseases 1 item
  21. Leukemia 4item
  22. Lung Cancer 5item
  23. Lymphoma 4item
  24. Melanoma 5item
  25. Multiple Myeloma 4item
  26. Myeloma 3item
  27. Neuroblastoma 2item
  28. Neuronal Protection 1 item
  29. Non-small Cell Lung Cancer 3item
  30. Non-small Cell Lung Carcinoma 1 item
  31. Ovarian Cancer 9item
  32. Pancreatic Cancer 3item
  33. Prostate Cancer 12item
  34. Renal Cancer 1 item
  35. Renal Cell Carcinoma 1 item
  36. Sarcoma 1 item
  37. Squamous Cell Carcinoma 1 item
  38. Testicular Cancer 2item
  39. Type 2 Diabetes 1 item